Weller, Michael http://orcid.org/0000-0002-1748-174X
Felsberg, Jörg
Hentschel, Bettina
Gramatzki, Dorothee
Kubon, Nadezhda
Wolter, Marietta
Reusche, Matthias
Roth, Patrick
Krex, Dietmar
Herrlinger, Ulrich
Westphal, Manfred
Tonn, Joerg C.
Regli, Luca
Maurage, Claude-Alain
von Deimling, Andreas
Pietsch, Torsten
Le Rhun, Emilie
Reifenberger, Guido
Funding for this research was provided by:
German Cancer Aid
University of Zurich
Article History
Received: 16 September 2023
Revised: 19 November 2023
Accepted: 20 November 2023
First Online: 6 January 2024
Declarations
:
: MiW has received research grants from Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Bayer, Curevac, Medac, Novartis, Novocure, Orbus, Philogen, Roche and Sandoz. PR has received honoraria for lectures or advisory board participation from Alexion, Bristol-Myers Squibb, Boehringer Ingelheim, Debiopharm, Midatech Pharma, Novocure, QED, and Roche and research support from Merck Sharp and Dohme and Novocure. DK received honoraria for advisory board participation from Novocure and Bayer and for lectures from Brainlab. UH has received lecture and/or advisory board honoraria from Medac and Bayer. MaW received honoraria for an advisory board from DoubleBond. JCT has received research grants from novocure and Munich Surgical Imaging and honoraria for lectures or consulting from Seagen and AAA-Novartis. ELR has received research grants from Bristol Meyers Squibb (BMS), and honoraria for lectures or advisory board participation or consulting from Bayer, Janssen, Leo Pharma, Pierre Fabre, Roche, Seattle Genetics, and Servier. JF, BH, DG, NK, MWo, MR, LR, CAM, AvD, TP, and GR declare no conflicts of interest.